{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:41:30Z","timestamp":1766180490871},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T00:00:00Z","timestamp":1332979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/jhg.2012.29","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T06:19:09Z","timestamp":1333001949000},"page":"283-285","source":"Crossref","is-referenced-by-count":15,"title":["Phenotype variations in Lafora progressive myoclonus epilepsy: possible involvement of genetic modifiers?"],"prefix":"10.1038","volume":"57","author":[{"given":"Shweta","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subramaniam","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,29]]},"reference":[{"key":"BFjhg201229_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajmg.1575","volume":"106","author":"AV Delgado-Escueta","year":"2001","unstructured":"Delgado-Escueta, A.V., Ganesh, S., Yamakawa, K. Advances in the genetics of progressive myoclonus epilepsy. Am. J. Med. Genet. 106, 129\u2013138 2001.","journal-title":"Am. J. Med. Genet."},{"key":"BFjhg201229_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10038-005-0321-1","volume":"51","author":"S Ganesh","year":"2006","unstructured":"Ganesh, S., Puri, R., Singh, S., Mittal, S., Dubey, D. Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy. J. Hum. Genet. 51, 1\u20138 2006.","journal-title":"J. Hum. Genet."},{"key":"BFjhg201229_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/humu.20954","volume":"30","author":"S Singh","year":"2009","unstructured":"Singh, S., Ganesh, S. Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes. Hum. Mutat 30, 715\u2013723 2009.","journal-title":"Hum. Mutat"},{"key":"BFjhg201229_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1528-1167.2009.02117.x","volume":"50","author":"N Ramachandran","year":"2009","unstructured":"Ramachandran, N., Girard, J.M., Turnbull, J., Minassian, B.A. The autosomal recessively inherited progressive myoclonus epilepsies and their genes. Epilepsia 50, 29\u201336 2009.","journal-title":"Epilepsia"},{"key":"BFjhg201229_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1212\/01.WNL.0000133215.65836.03","volume":"63","author":"EM Chan","year":"2004","unstructured":"Chan, E.M., Omer, S., Ahmed, M., Bridges, L.R., Bennett, C., Scherer, S.W., Minassian, B.A. Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus. Neurology 63, 565\u2013567 2004.","journal-title":"Neurology"},{"key":"BFjhg201229_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/hmg\/11.11.1263","volume":"11","author":"S Ganesh","year":"2002","unstructured":"Ganesh, S., Delgado-Escueta, A.V., Suzuki, T., Francheschetti, S., Riggio, C., Avanzini, G. et al Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype. Hum. Mol. Genet. 11, 1263\u20131271 2002.","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201229_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1212\/WNL.20.2.160","volume":"20","author":"M Sakai","year":"1970","unstructured":"Sakai, M., Austin, J., Witmer, F., Trueb, L. Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology 20, 160\u2013176 1970.","journal-title":"Neurology"},{"key":"BFjhg201229_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0009-8981(75)90093-5","volume":"62","author":"S Yokoi","year":"1975","unstructured":"Yokoi, S., Nakayama, H., Negishi, T. Biochemical studies on tissues from a patient with Lafora disease. Clin. Chim. Acta. 62, 415\u2013423 1975.","journal-title":"Clin. Chim. Acta."},{"key":"BFjhg201229_CR9","first-page":"1","volume":"6","author":"HL Busard","year":"1987","unstructured":"Busard, H.L., Renier, W.O., Gabre\u00ebls, F.J., Jaspar, H.H., Slooff, J.L., Janssen, A.J., Van Haelst, U.J. Lafora disease: a quantitative morphological and biochemical study of the cerebral cortex. Clin. Neuropathol. 6, 1\u20136 1987.","journal-title":"Clin. Neuropathol."},{"key":"BFjhg201229_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/hmg\/ddm339","volume":"17","author":"MC Solaz-Fuster","year":"2008","unstructured":"Solaz-Fuster, M.C., Gimeno-Alca\u00f1iz, J.V., Ros, S., Fernandez-Sanchez, M.E., Garcia-Fojeda, B., Criado Garcia, O. et al Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Hum. Mol. Genet. 17, 667\u2013678 2008.","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201229_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/hmg\/ddn398","volume":"18","author":"P Garyali","year":"2009","unstructured":"Garyali, P., Siwach, P., Singh, P.K., Puri, R., Mittal, S., Sengupta, S. et al The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system. Hum. Mol. Genet. 18, 688\u2013700 2009.","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201229_CR12","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1242\/jcs.082800","volume":"124","author":"S Sengupta","year":"2011","unstructured":"Sengupta, S., Badhwar, I., Upadhyay, M., Singh, S., Ganesh, S. Malin and laforin are essential components of a protein complex that protects cells from thermal stress. J. Cell Sci. 124, 2277\u20132286 2011.","journal-title":"J. Cell Sci."},{"key":"BFjhg201229_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1128\/MCB.06353-11","volume":"32","author":"PK Singh","year":"2012","unstructured":"Singh, P.K., Singh, S., Ganesh, S. Laforin-malin complex negatively regulates glycogen synthesis by modulating the cellular glucose uptake via glucose transporters. Mol. Cell Biol 32, 652\u2013663 2012.","journal-title":"Mol. Cell Biol"},{"key":"BFjhg201229_CR14","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1212\/01.WNL.0000154519.10805.F7","volume":"64","author":"C G\u00f3mez-Abad","year":"2005","unstructured":"G\u00f3mez-Abad, C., G\u00f3mez-Garre, P., Guti\u00e9rrez-Delicado, E., Saygi, S., Michelucci, R., Tassinari, C.A. et al Lafora disease due to EPM2B mutations: a clinical and genetic study. Neurology 64, 982\u2013986 2005.","journal-title":"Neurology"},{"key":"BFjhg201229_CR15","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1136\/jmg.2005.039479","volume":"43","author":"S Singh","year":"2006","unstructured":"Singh, S., Sethi, I., Francheschetti, S., Riggio, C., Avanzini, G., Yamakawa, K. et al Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy. J. Med. Genet. 43, e48 2006.","journal-title":"J. Med. Genet."},{"key":"BFjhg201229_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.0013-9580.2004.33203.x","volume":"45","author":"G Annesi","year":"2004","unstructured":"Annesi, G., Sofia, V., Gambardella, A., Candiano, I.C., Spadafora, P., Annesi, F. et al A novel exon 1 mutation in a patient with atypical Lafora progressive myoclonus epilepsy seen as childhood-onset cognitive deficit. Epilepsia 45, 294\u2013295 2004.","journal-title":"Epilepsia"},{"key":"BFjhg201229_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1528-1167.2006.00479.x","volume":"47","author":"S Franceschetti","year":"2006","unstructured":"Franceschetti, S., Gambardella, A., Canafoglia, L., Striano, P., Lohi, H., Gennaro, E. et al Clinical and genetic findings in 26 Italian patients with Lafora disease. Epilepsia 47, 640\u2013643 2006.","journal-title":"Epilepsia"},{"key":"BFjhg201229_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/j.1528-1167.2010.02692.x","volume":"51","author":"G Lesca","year":"2010","unstructured":"Lesca, G., Boutry-Kryza, N., de Toffol, B., Milh, M., Steschenko, D., Lemesle-Martin, M. et al Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora disease. Epilepsia 51, 1691\u20131698 2010.","journal-title":"Epilepsia"},{"key":"BFjhg201229_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10048-009-0190-4","volume":"10","author":"M Traor\u00e9","year":"2009","unstructured":"Traor\u00e9, M., Landour\u00e9, G., Motley, W., Sangar\u00e9, M., Meilleur, K., Coulibaly, S. et al Novel mutation in the NHLRC1 gene in a Malian family with a severe phenotype of Lafora disease. Neurogenetics 10, 319\u2013323 2009.","journal-title":"Neurogenetics"},{"key":"BFjhg201229_CR20","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/j.1528-1167.2005.00272.x","volume":"46","author":"B Baykan","year":"2005","unstructured":"Baykan, B., Striano, P., Gianotti, S., Bebek, N., Gennaro, E., Gurses, C., Zara, F. Late-onset and slow-progressing Lafora disease in four siblings with EPM2B mutation. Epilepsia 46, 1695\u20131697 2005.","journal-title":"Epilepsia"},{"key":"BFjhg201229_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/j.1528-1167.2007.01004.x","volume":"48","author":"C Gomez-Abad","year":"2007","unstructured":"Gomez-Abad, C., Afawi, Z., Korczyn, A.D., Misk, A., Shalev, S.A., Spiegel, R. et al Founder effect with variable age at onset in Arab families with Lafora disease and EPM2A mutation. Epilepsia 48, 1011\u20131014 2007.","journal-title":"Epilepsia"},{"key":"BFjhg201229_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/0883073807309245","volume":"23","author":"J Turnbull","year":"2008","unstructured":"Turnbull, J., Kumar, S., Ren, Z.P., Muralitharan, S., Naranian, T., Ackerley, C.A., Minassian, B.A. Lafora progressive myoclonus epilepsy: disease course homogeneity in a genetic isolate. J. Child Neurol. 23, 240\u2013242 2008.","journal-title":"J. Child Neurol."},{"key":"BFjhg201229_CR23","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1212\/01.wnl.0000260061.37559.67","volume":"68","author":"P G\u00f3mez-Garre","year":"2007","unstructured":"G\u00f3mez-Garre, P., Guti\u00e9rrez-Delicado, E., G\u00f3mez-Abad, C., Morales-Corraliza, J., Villanueva, V.E., Rodr\u00edguez de C\u00f3rdoba, S. et al Hepatic disease as the first manifestation of progressive myoclonusepilepsy of Lafora. Neurology 68, 1369\u20131373 2007.","journal-title":"Neurology"},{"key":"BFjhg201229_CR24","doi-asserted-by":"publisher","first-page":"e21294","DOI":"10.1371\/journal.pone.0021294","volume":"6","author":"R Guerrero","year":"2011","unstructured":"Guerrero, R., Vernia, S., Sanz, R., Abreu-Rodr\u00edguez, I., Almaraz, C., Garc\u00eda-Hoyos, M. et al A PTG variant contributes to a milder phenotype in Lafora disease. PLoS One 6, e21294 2011.","journal-title":"PLoS One"},{"key":"BFjhg201229_CR25","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nn1998","volume":"10","author":"D Vilchez","year":"2007","unstructured":"Vilchez, D., Ros, S., Cifuentes, D., Pujadas, L., Vall\u00e8s, J., Garc\u00eda-Fojeda, B. et al Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat. Neurosci. 10, 1407\u20131413 2007.","journal-title":"Nat. Neurosci."},{"key":"BFjhg201229_CR26","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","volume":"11","author":"S Ganesh","year":"2002","unstructured":"Ganesh, S., Delgado-Escueta, A.V., Sakamoto, T., Avila, M.R., Machado-Salas, J., Hoshii, Y. et al Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum. Mol. Genet. 11, 1251\u20131262 2002.","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201229_CR27","doi-asserted-by":"publisher","first-page":"25372","DOI":"10.1074\/jbc.M110.148668","volume":"285","author":"AA DePaoli-Roach","year":"2010","unstructured":"DePaoli-Roach, A.A., Tagliabracci, V.S., Segvich, D.M., Meyer, C.M., Irimia, J.M., Roach, P.J. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to Lafora bodies and the accumulation of insoluble laforin. J. Biol. Chem. 285, 25372\u201325381 2010.","journal-title":"J. Biol. Chem."},{"key":"BFjhg201229_CR28","doi-asserted-by":"publisher","first-page":"e1002037","DOI":"10.1371\/journal.pgen.1002037","volume":"7","author":"J Turnbull","year":"2011","unstructured":"Turnbull, J., DePaoli-Roach, A.A., Zhao, X., Cortez, M.A., Pencea, N., Tiberia, E. et al PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. PLoS Genet. 7, e1002037 2011.","journal-title":"PLoS Genet."},{"key":"BFjhg201229_CR29","doi-asserted-by":"publisher","first-page":"e5907","DOI":"10.1371\/journal.pone.0005907","volume":"4","author":"S Vernia","year":"2009","unstructured":"Vernia, S., Rubio, T., Heredia, M., Rodr\u00edguez de C\u00f3rdoba, S., Sanz, P. Increased endoplasmic reticulum stress and decreased proteasomal function in Lafora disease models lacking the phosphatase laforin. PLoS One 4, e5907 2009.","journal-title":"PLoS One"},{"key":"BFjhg201229_CR30","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/hmg\/ddq190","volume":"19","author":"C Aguado","year":"2010","unstructured":"Aguado, C., Sarkar, S., Korolchuk, V.I., Criado, O., Vernia, S., Boya, P. et al Laforin, the most common protein mutated in Lafora disease, regulates autophagy. Hum. Mol. Genet. 19, 2867\u20132876 2010.","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201229_CR31","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/hmg\/ddr590","volume":"21","author":"O Criado","year":"2011","unstructured":"Criado, O., Aguado, C., Gayarre, J., Duran-Trio, L., Garcia-Cabrero, A.M., Vernia, S. et al Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy. Hum. Mol. Genet. 21, 1521\u20131533 2011.","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201229_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/hmg\/ddr452","volume":"21","author":"R Puri","year":"2012","unstructured":"Puri, R., Suzuki, T., Yamakawa, K., Ganesh, S. Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease. Hum. Mol. Genet. 21, 175\u2013184 2012.","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201229_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/35056009","volume":"2","author":"JH Nadeau","year":"2001","unstructured":"Nadeau, J.H. Modifier genes in mice and humans. Nat. Rev. Genet. 2, 165\u2013174 2001.","journal-title":"Nat. Rev. Genet."},{"key":"BFjhg201229_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1749-6632.2010.05879.x","volume":"1214","author":"GR Cutting","year":"2010","unstructured":"Cutting, G.R. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann. N. Y. Acad. Sci. 1214, 57\u201369 2010.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFjhg201229_CR35","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/hmg\/ddg253","volume":"12","author":"S Ganesh","year":"2003","unstructured":"Ganesh, S., Tsurutani, N., Suzuki, T., Ueda, K., Agarwala, K.L., Osada, H. et al The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain. Hum. Mol. Genet. 12, 2359\u20132368 2003.","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201229_CR36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0888-7543(03)00094-6","volume":"81","author":"L Ianzano","year":"2003","unstructured":"Ianzano, L., Zhao, X.C., Minassian, B.A., Scherer, S.W. Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product. Genomics 81, 579\u2013587 2003.","journal-title":"Genomics"},{"key":"BFjhg201229_CR37","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1093\/hmg\/ddi306","volume":"14","author":"H Lohi","year":"2005","unstructured":"Lohi, H., Ianzano, L., Zhao, X.C., Chan, E.M., Turnbull, J., Scherer, S.W. et al Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy. Hum. Mol. Genet. 14, 2727\u20132736 2005.","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201229_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ccr.2006.08.008","volume":"10","author":"Y Wang","year":"2006","unstructured":"Wang, Y., Liu, Y., Wu, C., Zhang, H., Zheng, X., Zheng, Z. et al Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling. Cancer Cell 10, 179\u2013190 2006.","journal-title":"Cancer Cell"},{"key":"BFjhg201229_CR39","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1101\/gad.1553207","volume":"21","author":"A Cheng","year":"2007","unstructured":"Cheng, A., Zhang, M., Gentry, M.S., Worby, C.A., Dixon, J.E., Saltiel, A.R. A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease. Genes Dev. 21, 2399\u20132409 2007.","journal-title":"Genes Dev."},{"key":"BFjhg201229_CR40","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1091\/mbc.e10-03-0227","volume":"21","author":"D Moreno","year":"2010","unstructured":"Moreno, D., Towler, M.C., Hardie, D.G., Knecht, E., Sanz, P. The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits. Mol. Biol. Cell. 21, 2578\u20132588 2010.","journal-title":"Mol. Biol. Cell."},{"key":"BFjhg201229_CR41","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1093\/hmg\/ddg340","volume":"12","author":"ME Fern\u00e1ndez-S\u00e1nchez","year":"2003","unstructured":"Fern\u00e1ndez-S\u00e1nchez, M.E., Criado-Garc\u00eda, O., Heath, K.E., Garc\u00eda-Fojeda, B., Medra\u00f1o-Fern\u00e1ndez, I., Gomez-Garre, P. et al Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Hum. Mol. Genet 12, 3161\u20133171 2003.","journal-title":"Hum. Mol. Genet"},{"key":"BFjhg201229_CR42","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1074\/jbc.M708712200","volume":"283","author":"CA Worby","year":"2008","unstructured":"Worby, C.A., Gentry, M.S., Dixon, J.E. Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG). J. Biol. Chem. 283, 4069\u20134076 2008.","journal-title":"J. Biol. Chem."},{"key":"BFjhg201229_CR43","doi-asserted-by":"publisher","first-page":"22657","DOI":"10.1074\/jbc.M109.009688","volume":"284","author":"R Puri","year":"2009","unstructured":"Puri, R., Suzuki, T., Yamakawa, K., Ganesh, S. Hyperphosphorylation and aggregation of Tau in laforin-deficient mice, an animal model for Lafora disease. J. Biol. Chem. 284, 22657\u201322663 2009.","journal-title":"J. Biol. Chem."},{"key":"BFjhg201229_CR44","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1074\/jbc.M109.006312","volume":"285","author":"SN Rao","year":"2010","unstructured":"Rao, S.N., Sharma, J., Maity, R., Jana, N.R. Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease. J. Biol. Chem. 285, 1404\u20131413 2010.","journal-title":"J. Biol. Chem."},{"key":"BFjhg201229_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.nbd.2011.06.013","volume":"44","author":"J Sharma","year":"2011","unstructured":"Sharma, J., Rao, S.N., Shankar, S.K., Satishchandra, P., Jana, N.R. Lafora disease ubiquitin ligase malin promotes proteasomal degradation of neuronatin and regulates glycogen synthesis. Neurobiol. Dis. 44, 133\u2013141 2011.","journal-title":"Neurobiol. Dis."},{"key":"BFjhg201229_CR46","doi-asserted-by":"publisher","first-page":"6830","DOI":"10.1074\/jbc.M111.315135","volume":"287","author":"J Sharma","year":"2012","unstructured":"Sharma, J., Mulherkar, S., Mukherjee, D., Jana, N.R. Malin regulates Wnt signalling pathway through degradation of dishevelled 2. J. Biol. Chem. 287, 6830\u20136839 2012.","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg201229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201229","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:30:23Z","timestamp":1684431023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg201229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,29]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["BFjhg201229"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2012.29","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,29]]}}}